Caris Life Sciences Caris Life Sciences is a molecular science company that provides cancer care services. | Beckman Coulter Life Sciences Beckman Coulter Life Sciences is a company that focuses on healthcare through discovery and research. | Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. | ![]() Oklahoma Medical Research Foundation Oklahoma Medical Research Foundation (OMRF) is a nonprofit biomedical research company. | ![]() Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. | |||
Founding Date | Founding Date 2008 | Founding Date 1996 | Founding Date 1935 | Founding Date 1999 | Founding Date 2008 | Founding Date 1946 | Founding Date 2012 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||||
Locations | Locations Sunnyvale, US HQ North Ryde, AU Geel, BE São Paulo, BR Shanghai, CN København, DK Espoo, FI see more | Locations Indianapolis, US HQ São Paulo, BR Luzerne, SG Bratislava, SK Centurion, ZA Istanbul, TR Dubai, AE | Locations Carlsbad, US HQ | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | Locations Oklahoma City, US HQ | Locations Redwood City, US HQ | |
Employees | Employees 1,468 | Employees 4,7812% decrease | Employees 2,244 | Employees 1471% increase | Employees 8154% increase | Employees 5151% increase | Employees 1,7681% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) N/A | Valuation ($) 2.7 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) $812m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $982m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $362.5m (FY, 2025) | Gross profit N/A | Gross profit $633m (FY, 2025) |
Net income | Net income ($68.1m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income $66.4m (FY, 2025) | Net income N/A | Net income ($416.3m) (FY, 2025) |
Operating ⚠ | |||||||
Tests | Tests N/A | Tests 28 (Jan, 2023) | Tests N/A | Tests N/A | Tests 26.4 k (Q3, 2022) | Tests N/A | Tests N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 98.9m | Total funding raised N/A | Total funding raised $ 28m | Total funding raised $ 116.3m | Total funding raised $ 19.3m | Total funding raised $ 550m |

Cepheid is a company that develops molecular diagnostic systems and tests.
View companyBeckman Coulter Life Sciences is a company that focuses on healthcare through discovery and research.
View company
Genoptix is a company operating as a specialty oncology laboratory.
View companyVeracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View company